Annual Cash & Cash Equivalents:
$104.71M-$5.93M(-5.36%)Summary
- As of today, BCRX annual cash & cash equivalents is $104.71 million, with the most recent change of -$5.93 million (-5.36%) on December 31, 2024.
- During the last 3 years, BCRX annual cash & cash equivalents has fallen by -$399.68 million (-79.24%).
- BCRX annual cash & cash equivalents is now -79.24% below its all-time high of $504.39 million, reached on December 31, 2021.
Performance
BCRX Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$213.45M-$47.08M(-18.07%)Summary
- As of today, BCRX quarterly cash & cash equivalents is $213.45 million, with the most recent change of -$47.08 million (-18.07%) on September 30, 2025.
- Over the past year, BCRX quarterly cash & cash equivalents has dropped by -$117.37 million (-35.48%).
- BCRX quarterly cash & cash equivalents is now -58.22% below its all-time high of $510.95 million, reached on December 31, 2021.
Performance
BCRX Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BCRX Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -5.4% | -35.5% |
| 3Y3 Years | -79.2% | -50.2% |
| 5Y5 Years | -8.3% | +46.7% |
BCRX Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -79.2% | at low | -50.2% | at low |
| 5Y | 5-Year | -79.2% | at low | -58.2% | +46.7% |
| All-Time | All-Time | -79.2% | +3778.3% | -58.2% | >+9999.0% |
BCRX Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $213.45M(-18.1%) |
| Jun 2025 | - | $260.53M(-11.8%) |
| Mar 2025 | - | $295.38M(-8.0%) |
| Dec 2024 | $104.71M(-5.4%) | $321.06M(-3.0%) |
| Sep 2024 | - | $330.83M(+20.8%) |
| Jun 2024 | - | $273.82M(-19.1%) |
| Mar 2024 | - | $338.35M(-13.4%) |
| Dec 2023 | $110.64M(-63.7%) | $390.79M(-2.1%) |
| Sep 2023 | - | $399.17M(-3.2%) |
| Jun 2023 | - | $412.24M(+3.2%) |
| Mar 2023 | - | $399.62M(-6.1%) |
| Dec 2022 | $304.77M(-39.6%) | $425.78M(-0.6%) |
| Sep 2022 | - | $428.30M(+2.2%) |
| Jun 2022 | - | $418.93M(-6.2%) |
| Mar 2022 | - | $446.82M(-12.6%) |
| Dec 2021 | $504.39M(+85.4%) | $510.95M(+150.6%) |
| Sep 2021 | - | $203.89M(-8.5%) |
| Jun 2021 | - | $222.78M(-8.8%) |
| Mar 2021 | - | $244.36M(-19.2%) |
| Dec 2020 | $272.13M(+138.3%) | $302.59M(+107.9%) |
| Sep 2020 | - | $145.53M(-24.0%) |
| Jun 2020 | - | $191.59M(+67.2%) |
| Mar 2020 | - | $114.62M(-16.8%) |
| Dec 2019 | $114.17M(+327.1%) | $137.78M(+96.9%) |
| Sep 2019 | - | $69.98M(-27.7%) |
| Jun 2019 | - | $96.78M(-12.0%) |
| Mar 2019 | - | $109.95M(+3.7%) |
| Dec 2018 | $26.73M(-46.8%) | $106.01M(-13.0%) |
| Sep 2018 | - | $121.83M(+37.9%) |
| Jun 2018 | - | $88.36M(-7.9%) |
| Mar 2018 | - | $95.91M(-18.5%) |
| Dec 2017 | $50.28M(+127.5%) | $117.68M(-28.6%) |
| Sep 2017 | - | $164.75M(+91.5%) |
| Jun 2017 | - | $86.03M(-15.2%) |
| Mar 2017 | - | $101.48M(+80.6%) |
| Dec 2016 | $22.10M(-23.5%) | $56.20M(+3.4%) |
| Sep 2016 | - | $54.33M(+35.3%) |
| Jun 2016 | - | $40.17M(+6.3%) |
| Mar 2016 | - | $37.78M(-47.5%) |
| Dec 2015 | $28.90M(-47.0%) | - |
| Sep 2015 | - | $71.95M(-25.0%) |
| Jun 2015 | - | $95.93M(+36.7%) |
| Mar 2015 | - | $70.16M(-3.8%) |
| Dec 2014 | $54.54M(+157.7%) | $72.92M(-42.7%) |
| Sep 2014 | - | $127.28M(-3.8%) |
| Jun 2014 | - | $132.26M(+319.3%) |
| Mar 2014 | - | $31.54M(-17.4%) |
| Dec 2013 | $21.16M(+1.3%) | $38.21M(-10.6%) |
| Sep 2013 | - | $42.74M(+36.8%) |
| Jun 2013 | - | $31.25M(+8.2%) |
| Mar 2013 | - | $28.88M(-19.6%) |
| Dec 2012 | $20.89M(+27.0%) | $35.91M(-13.1%) |
| Sep 2012 | - | $41.32M(+11.3%) |
| Jun 2012 | - | $37.11M(-16.1%) |
| Mar 2012 | - | $44.23M(+4.5%) |
| Dec 2011 | $16.44M(+20.7%) | $42.34M(-5.1%) |
| Sep 2011 | - | $44.62M(-24.4%) |
| Jun 2011 | - | $59.01M(-14.6%) |
| Mar 2011 | - | $69.10M(+26.6%) |
| Dec 2010 | $13.62M | $54.57M(-11.1%) |
| Sep 2010 | - | $61.39M(+9.3%) |
| Jun 2010 | - | $56.18M(-11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $63.67M(-8.5%) |
| Dec 2009 | $41.12M(+84.1%) | $69.59M(+96.1%) |
| Sep 2009 | - | $35.48M(-16.0%) |
| Jun 2009 | - | $42.26M(-22.1%) |
| Mar 2009 | - | $54.21M(-11.9%) |
| Dec 2008 | $22.34M(-28.3%) | $61.53M(-4.9%) |
| Sep 2008 | - | $64.68M(+68.4%) |
| Jun 2008 | - | $38.40M(-15.7%) |
| Mar 2008 | - | $45.55M(-10.2%) |
| Dec 2007 | $31.16M(+605.3%) | $50.70M(-26.2%) |
| Sep 2007 | - | $68.71M(+122.6%) |
| Jun 2007 | - | $30.87M(-16.7%) |
| Mar 2007 | - | $37.06M(-1.1%) |
| Dec 2006 | $4.42M(-84.8%) | $37.46M(-14.5%) |
| Sep 2006 | - | $43.81M(-20.0%) |
| Jun 2006 | - | $54.77M(-20.0%) |
| Mar 2006 | - | $68.44M(+36.2%) |
| Dec 2005 | $29.16M(+229.9%) | $50.26M(+63.0%) |
| Sep 2005 | - | $30.84M(-6.7%) |
| Jun 2005 | - | $33.05M(-19.5%) |
| Mar 2005 | - | $41.04M(+77.1%) |
| Dec 2004 | $8.84M(+5.9%) | $23.17M(+1.0%) |
| Sep 2004 | - | $22.95M(-5.0%) |
| Jun 2004 | - | $24.16M(-15.3%) |
| Mar 2004 | - | $28.52M(+42.4%) |
| Dec 2003 | $8.35M(-39.6%) | $20.03M(+3.0%) |
| Sep 2003 | - | $19.45M(-22.5%) |
| Jun 2003 | - | $25.10M(+9.8%) |
| Mar 2003 | - | $22.86M(-6.5%) |
| Dec 2002 | $13.82M(-26.7%) | $24.45M(-10.0%) |
| Sep 2002 | - | $27.16M(+1.1%) |
| Jun 2002 | - | $26.88M(-8.1%) |
| Mar 2002 | - | $29.26M(-8.5%) |
| Dec 2001 | $18.87M(+123.1%) | $31.99M(+3.2%) |
| Sep 2001 | - | $31.01M(-3.4%) |
| Jun 2001 | - | $32.09M(-3.5%) |
| Mar 2001 | - | $33.26M(+35.0%) |
| Dec 2000 | $8.46M(-1.7%) | $24.64M(-3.8%) |
| Sep 2000 | - | $25.61M(-3.1%) |
| Jun 2000 | - | $26.43M(-1.0%) |
| Mar 2000 | - | $26.69M(+43.3%) |
| Dec 1999 | $8.60M(-30.1%) | - |
| Mar 1999 | - | $18.63M(+12.6%) |
| Dec 1998 | $12.30M(+223.7%) | - |
| Sep 1998 | - | $16.54M(-14.2%) |
| Jun 1998 | - | $19.28M(-3.9%) |
| Mar 1998 | - | $20.06M(+427.9%) |
| Dec 1997 | $3.80M(+5.6%) | $3.80M(-32.1%) |
| Sep 1997 | - | $5.60M(+19.1%) |
| Jun 1997 | - | $4.70M(+38.2%) |
| Mar 1997 | - | $3.40M(-5.6%) |
| Dec 1996 | $3.60M(-41.0%) | $3.60M(-44.6%) |
| Sep 1996 | - | $6.50M(+3.2%) |
| Jun 1996 | - | $6.30M(-34.4%) |
| Mar 1996 | - | $9.60M(+57.4%) |
| Dec 1995 | $6.10M(+125.9%) | $6.10M(-53.1%) |
| Sep 1995 | - | $13.00M(-10.3%) |
| Jun 1995 | - | $14.50M(+705.6%) |
| Mar 1995 | - | $1.80M(-33.3%) |
| Dec 1994 | $2.70M | $2.70M(-42.6%) |
| Sep 1994 | - | $4.70M(+46.9%) |
| Jun 1994 | - | $3.20M(-52.2%) |
| Mar 1994 | - | $6.70M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of BCRX is $104.71M
What is the all-time high annual cash & cash equivalents for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $504.39M
What is BioCryst Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, BCRX annual cash & cash equivalents has changed by -$5.93M (-5.36%)
What is BioCryst Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BCRX is $213.45M
What is the all-time high quarterly cash & cash equivalents for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $510.95M
What is BioCryst Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, BCRX quarterly cash & cash equivalents has changed by -$117.37M (-35.48%)